<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01555567</url>
  </required_header>
  <id_info>
    <org_study_id>ACLNMES</org_study_id>
    <secondary_id>1K08AR053152-01A2</secondary_id>
    <nct_id>NCT01555567</nct_id>
  </id_info>
  <brief_title>Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury</brief_title>
  <official_title>Quadriceps Inhibition After ACL Injury: Neuromuscular and Functional Consequences</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Quadriceps muscle weakness is a common consequence of ACL injury. This muscle weakness is
      considered to result from neural inhibition preventing full muscle contraction and is
      referred to as arthrogenic muscle inhibition (AMI). AMI hinders rehabilitation by preventing
      gains in strength, increasing the risk of re-injury, and potentially placing patients at risk
      for chronic degenerative joint conditions. Quadriceps weakness that occurs following ACL
      injury is also thought to be caused by muscle atrophy which is thought to manifest due to
      alterations in muscle architecture, selective fiber atrophy or even neural deficits such as
      AMI. Importantly, interventions that are designed to counter this muscle weakness are
      required in order to promote long-term knee joint health. Hence, the purpose of the current
      study is to determine the efficacy of interventions that target quadriceps weakness to
      improve quadriceps muscle function and biomechanics in patients prior to and following ACL
      reconstruction. Specifically, the efficacy of neuromuscular electrical stimulation aimed at
      improving quadriceps neural activity and eccentric exercise intended to minimize quadriceps
      muscle atrophy will be investigated. The investigators expect that patients who receive the
      electrical stimulation therapy will demonstrate improvements in quadriceps strength and
      activation. Furthermore, it is expected that patients who receive both the electrical
      stimulation and eccentric intervention will demonstrate markedly greater gains in quadriceps
      strength and activation than patients who receive only the electrical stimulation therapy or
      standard of care post-surgery. The investigators also hypothesize that the patients who
      receive the electrical stimulation therapy and/or eccentrics will display knee motion similar
      to uninjured control subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuromuscular electrical stimulation (NMES) has been shown to reduce quadriceps activation
      failure (QAF) and eccentric exercise has been shown to lessen muscle atrophy post-ACL
      reconstruction. Given thatthese are two critical components of quadriceps strength,
      intervention combining these therapies may be effective at reinstituting quadriceps function
      post-reconstruction. Therefore, the aim of this study is to evaluate the effectiveness of a
      combined NMES and eccentric exercise intervention to improve the recovery of quadriceps
      activation and strength post-reconstruction. Patients post ACL-injury will be placed into
      four treatment groups (NMES and eccentrics; eccentrics only; NMES only, and standard of care)
      Patients assigned to the NMES and eccentric and the NMES only groups will receive the NMES
      protocol 2× per week for the first 6 weeks post-reconstruction. MES and eccentric and the
      eccentrics only groups will receive the eccentric exercise protocol 2× perweek beginning 6
      weeks post-reconstruction. Quadriceps activation was assessed via the superimposed burst
      technique and quantified via the central activation ratio.Quadriceps strength was assessed
      via maximal voluntary isomeric contractions (Nm/kg). Data will be gathered on three
      occasions: pre-operative, 12-weeks-post-surgery and at return-to-play.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quadriceps Strength</measure>
    <time_frame>Time of return to activity (~6 months following surgery)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Central Activation Ratio</measure>
    <time_frame>Time of return to activity (~6 months following surgery)</time_frame>
    <description>CAR = maximal voluntary isometric contractions force / maximal voluntary isometric contractions force + stimulated force</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Anterior Cruciate Ligament Injury</condition>
  <arm_group>
    <arm_group_label>Electrical stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects placed into this group will undergo electrical stimulation following anterior cruciate ligament reconstruction (ACLr). Subjects will be required to report 2 times per week for 6 weeks following ACLr for electrical stimulation therapy. Electrical stimulation therapy post-reconstruction will commence immediately post-ACLr and end at week 6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will undergo standard ACL rehabilitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eccentric Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects placed into this group will undergo eccentric exercise strength training following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr. Eccentric strengthening will begin at week 6 post-ACLr and will end at week 12 post-ACLr.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stimulation and Eccentrics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects placed into this group will undergo a combined electrical stimulation and eccentric exercise intervention following ACLr. The electrical stimulation intervention will be delivered immediately following ACLr and will end at 6 weeks post-ACLr. Subjects will receive the electrical stimulation therapy 2 times per week for the first 6 weeks post-ACLr. At six weeks post-ACLr, subjects will begin the eccentric strengthening protocol. Subjects will eccentrically train 2 times per week for 6 weeks. The eccentric strengthening will end at 12 weeks post-ACLr.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrical Stimulation</intervention_name>
    <description>Electrical stimulation will be delivered 2 times per week</description>
    <arm_group_label>Electrical stimulation</arm_group_label>
    <arm_group_label>Stimulation and Eccentrics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Eccentric Exercise</intervention_name>
    <description>Eccentric Exercise will be delivered 2 times per week</description>
    <arm_group_label>Eccentric Exercise</arm_group_label>
    <arm_group_label>Stimulation and Eccentrics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 14-35 years

          -  Willingness to participate in testing and follow-up as outlined in the protocol

          -  Scheduled to undergo ACL reconstruction

        Exclusion Criteria:

          -  Previous quadriceps injury

          -  Inability to provide informed consent

          -  Pregnant females

          -  ACL injury sustained more than 48 hours prior to reporting to physician

          -  ACL injury sustained when not engaged in sports participation (i.e. while engaged in
             activities of daily living)

          -  Previous partial ACL tear

          -  Previous surgery to injured knee

          -  Total or partial meniscectomy accompanying ACL reconstruction

          -  Other ligamentous injury accompanying ACL injury
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Riann M Palmieri-Smith, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MedSport</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2012</study_first_posted>
  <results_first_submitted>April 26, 2015</results_first_submitted>
  <results_first_submitted_qc>May 12, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 14, 2015</results_first_posted>
  <last_update_submitted>May 13, 2015</last_update_submitted>
  <last_update_submitted_qc>May 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Riann Palmieri-Smith</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>ACL</keyword>
  <keyword>muscle</keyword>
  <keyword>quadriceps</keyword>
  <keyword>strength</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Anterior Cruciate Ligament Injuries</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Neuromuscular Electrical Stimulation</title>
          <description>Subjects placed into this group will undergo neuromuscular electrical stimulation (NMES) following anterior cruciate ligament (ACLr). Subjects will be required to report 2 times per week for 6 weeks following ACLr for NMES therapy. NMES therapy post-reconstruction will commence immediately post-ACLr and end at week 6.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week</description>
        </group>
        <group group_id="P2">
          <title>Standard of Care</title>
          <description>This group will undergo standard ACL rehabilitation</description>
        </group>
        <group group_id="P3">
          <title>Eccentric Exercise</title>
          <description>Subjects placed into this group will undergo eccentric exercise strength training following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr. Eccentric strengthening will begin at week 6 post-ACLr and will end at week 12 post-ACLr.
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
        </group>
        <group group_id="P4">
          <title>Combination of NMES and Eccentric Exercise</title>
          <description>Subjects placed into this group will undergo a combined NMES and eccentric exercise intervention following ACLr. The NMES intervention will be delivered immediately following ACLr and will end at 6 weeks post-ACLr. Subjects will receive the NMES therapy 2 times per week for the first 6 weeks post-ACLr. At six weeks post-ACLr, subjects will begin the eccentric strengthening protocol. Subjects will eccentrically train 2 times per week for 6 weeks. The eccentric strengthening will end at 12 weeks post-ACLr.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>12 Week</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="9"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Return to Activity</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Neuromuscular Electrical Stimulation</title>
          <description>Subjects placed into this group will undergo NMES following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr for NMES therapy. NMES therapy post-reconstruction will commence immediately post-ACLr and end at week 6.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week</description>
        </group>
        <group group_id="B2">
          <title>Standard of Care</title>
          <description>This group will undergo standard ACL rehabilitation</description>
        </group>
        <group group_id="B3">
          <title>Eccentric Exercise</title>
          <description>Subjects placed into this group will undergo eccentric exercise strength training following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr. Eccentric strengthening will begin at week 6 post-ACLr and will end at week 12 post-ACLr.
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
        </group>
        <group group_id="B4">
          <title>Combination of NMES and Eccentric Exercise</title>
          <description>Subjects placed into this group will undergo a combined NMES and eccentric exercise intervention following ACLr. The NMES intervention will be delivered immediately following ACLr and will end at 6 weeks post-ACLr. Subjects will receive the NMES therapy 2 times per week for the first 6 weeks post-ACLr. At six weeks post-ACLr, subjects will begin the eccentric strengthening protocol. Subjects will eccentrically train 2 times per week for 6 weeks. The eccentric strengthening will end at 12 weeks post-ACLr.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="8"/>
            <count group_id="B4" value="8"/>
            <count group_id="B5" value="36"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.8" spread="4.4"/>
                    <measurement group_id="B2" value="18.3" spread="3.7"/>
                    <measurement group_id="B3" value="23.2" spread="5.4"/>
                    <measurement group_id="B4" value="23.2" spread="6.3"/>
                    <measurement group_id="B5" value="21.6" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>meter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.76" spread=".1"/>
                    <measurement group_id="B2" value="1.73" spread=".1"/>
                    <measurement group_id="B3" value="1.75" spread=".1"/>
                    <measurement group_id="B4" value="1.45" spread=".6"/>
                    <measurement group_id="B5" value="1.67" spread=".22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mass</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81.65" spread="22.6"/>
                    <measurement group_id="B2" value="75.5" spread="24.1"/>
                    <measurement group_id="B3" value="77.7" spread="10.4"/>
                    <measurement group_id="B4" value="77.8" spread="16.5"/>
                    <measurement group_id="B5" value="78.2" spread="18.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Quadriceps Strength</title>
          <units>Nm/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.6" spread=".6"/>
                    <measurement group_id="B2" value="2.6" spread=".6"/>
                    <measurement group_id="B3" value="2.8" spread="1.1"/>
                    <measurement group_id="B4" value="2.7" spread=".8"/>
                    <measurement group_id="B5" value="2.67" spread=".78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Central Activation Ratio (CAR)</title>
          <description>CAR = maximal voluntary isometric contraction force / maximal voluntary isometric contractions force + stimulated force</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97.4" spread="3"/>
                    <measurement group_id="B2" value="94.9" spread="5.3"/>
                    <measurement group_id="B3" value="95.9" spread="4.5"/>
                    <measurement group_id="B4" value="95.7" spread="3.5"/>
                    <measurement group_id="B5" value="95.9" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quadriceps Strength</title>
        <time_frame>Time of return to activity (~6 months following surgery)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neuromuscular Electrical Stimulation</title>
            <description>Subjects placed into this group will undergo NMES following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr for NMES therapy. NMES therapy post-reconstruction will commence immediately post-ACLr and end at week 6.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>This group will undergo standard ACL rehabilitation</description>
          </group>
          <group group_id="O3">
            <title>Eccentric Exercise</title>
            <description>Subjects placed into this group will undergo eccentric exercise strength training following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr. Eccentric strengthening will begin at week 6 post-ACLr and will end at week 12 post-ACLr.
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
          </group>
          <group group_id="O4">
            <title>Combination of NMES and Eccentric Exercise</title>
            <description>Subjects placed into this group will undergo a combined NMES and eccentric exercise intervention following ACLr. The NMES intervention will be delivered immediately following ACLr and will end at 6 weeks post-ACLr. Subjects will receive the NMES therapy 2 times per week for the first 6 weeks post-ACLr. At six weeks post-ACLr, subjects will begin the eccentric strengthening protocol. Subjects will eccentrically train 2 times per week for 6 weeks. The eccentric strengthening will end at 12 weeks post-ACLr.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
          </group>
        </group_list>
        <measure>
          <title>Quadriceps Strength</title>
          <units>Nm/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.6"/>
                    <measurement group_id="O2" value="2.1" spread="0.6"/>
                    <measurement group_id="O3" value="2.8" spread="0.9"/>
                    <measurement group_id="O4" value="2.9" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Central Activation Ratio</title>
        <description>CAR = maximal voluntary isometric contractions force / maximal voluntary isometric contractions force + stimulated force</description>
        <time_frame>Time of return to activity (~6 months following surgery)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neuromuscular Electrical Stimulation</title>
            <description>Subjects placed into this group will undergo NMES following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr for NMES therapy. NMES therapy post-reconstruction will commence immediately post-ACLr and end at week 6.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>This group will undergo standard ACL rehabilitation</description>
          </group>
          <group group_id="O3">
            <title>Eccentric Exercise</title>
            <description>Subjects placed into this group will undergo eccentric exercise strength training following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr. Eccentric strengthening will begin at week 6 post-ACLr and will end at week 12 post-ACLr.
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
          </group>
          <group group_id="O4">
            <title>Combination of NMES and Eccentric Exercise</title>
            <description>Subjects placed into this group will undergo a combined NMES and eccentric exercise intervention following ACLr. The NMES intervention will be delivered immediately following ACLr and will end at 6 weeks post-ACLr. Subjects will receive the NMES therapy 2 times per week for the first 6 weeks post-ACLr. At six weeks post-ACLr, subjects will begin the eccentric strengthening protocol. Subjects will eccentrically train 2 times per week for 6 weeks. The eccentric strengthening will end at 12 weeks post-ACLr.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
          </group>
        </group_list>
        <measure>
          <title>Central Activation Ratio</title>
          <description>CAR = maximal voluntary isometric contractions force / maximal voluntary isometric contractions force + stimulated force</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.8" spread="4.6"/>
                    <measurement group_id="O2" value="91.8" spread="9"/>
                    <measurement group_id="O3" value="98.1" spread="1.2"/>
                    <measurement group_id="O4" value="97.6" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Neuromuscular Electrical Stimulation</title>
          <description>Subjects placed into this group will undergo NMES following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr for NMES therapy. NMES therapy post-reconstruction will commence immediately post-ACLr and end at week 6.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week</description>
        </group>
        <group group_id="E2">
          <title>Standard of Care</title>
          <description>This group will undergo standard ACL rehabilitation</description>
        </group>
        <group group_id="E3">
          <title>Eccentric Exercise</title>
          <description>Subjects placed into this group will undergo eccentric exercise strength training following ACLr. Subjects will be required to report 2 times per week for 6 weeks following ACLr. Eccentric strengthening will begin at week 6 post-ACLr and will end at week 12 post-ACLr.
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
        </group>
        <group group_id="E4">
          <title>Combination of NMES and Eccentric Exercise</title>
          <description>Subjects placed into this group will undergo a combined NMES and eccentric exercise intervention following ACLr. The NMES intervention will be delivered immediately following ACLr and will end at 6 weeks post-ACLr. Subjects will receive the NMES therapy 2 times per week for the first 6 weeks post-ACLr. At six weeks post-ACLr, subjects will begin the eccentric strengthening protocol. Subjects will eccentrically train 2 times per week for 6 weeks. The eccentric strengthening will end at 12 weeks post-ACLr.
Neuromuscular Electrical Stimulation: NMES will be delivered 2 times per week
Eccentric Exercise: Eccentric Exercise will be delivered 2 times per week</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Riann Palmieri-Smith</name_or_title>
      <organization>University of Michigan</organization>
      <phone>7346153154</phone>
      <email>riannp@umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

